Literature DB >> 11022072

Morphological and functional characteristics of patent foramen ovale and their embolic implications.

S De Castro1, D Cartoni, M Fiorelli, M Rasura, A Anzini, E M Zanette, M Beccia, C Colonnese, F Fedele, C Fieschi, N G Pandian.   

Abstract

BACKGROUND AND
PURPOSE: Transesophageal echocardiography (TEE) has detected a high prevalence of patent foramen ovale (PFO) in stroke patients, but the clinical implications of the distinctive characteristics of this patency are still a matter of debate.
METHODS: We studied 350 patients with acute ischemic stroke or transient ischemic attack (TIA) within 1 week of admission. Of these, 101 (29%) were identified by contrast TEE to have a PFO; 86 patients (25%) were cryptogenic stroke patients, and 163 were excluded because of the presence of a definite or possible arterial or clinical evidence of a source of emboli or small-vessel disease. Thirteen PFO subjects without a history of embolism were designated as the control group. All PFO and cryptogenic stroke patients were followed up by neurological visits.
RESULTS: Compared with controls, PFO patients with acute stroke or TIA more frequently presented with a right-to-left shunt at rest and a higher membrane mobility (P:<0. 05). Patients with these characteristics were considered to be at high risk. During a median follow-up period of 31 months (range, 4 to 58 months), 8 PFO and 18 cryptogenic stroke patients experienced recurrent cerebrovascular events. The cumulative estimate of risk of cerebrovascular event recurrence at 3 years was 4.3% (95% confidence interval [CI], 0% to 10.2%) for "low-risk" PFO patients, 12.5% (95% CI, 0% to 26.1%) for "high-risk" PFO patients, and 16.3% (95% CI, 7. 2% to 25.4%) for cryptogenic stroke patients (high-risk PFO versus low-risk PFO, P:=0.05).
CONCLUSIONS: The association of right-to-left shunting at rest and high membrane mobility, as detected by contrast TEE, seems to identify PFO patients with cerebrovascular ischemic events who are at higher risk for recurrent brain embolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022072     DOI: 10.1161/01.str.31.10.2407

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  57 in total

1.  Risks of tumor embolization in the presence of an unrecognized patent foramen ovale: case report.

Authors:  Michael Bruce Horowitz; Ricardo Carrau; Donald Crammond; Emanuel Kanal
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

2.  Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy.

Authors:  M Schwerzmann; S Windecker; A Wahl; H Mehta; K Nedeltchev; H Mattle; C Seiler; B Meier
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 3.  Indications for the closure of patent foramen ovale.

Authors:  Michael J Landzberg; Paul Khairy
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

4.  Patent foramen ovale and stroke: Should PFOs be closed in otherwise cryptogenic stroke?

Authors:  David A Carpenter; Andria L Ford; Jin-Moo Lee
Journal:  Curr Atheroscler Rep       Date:  2010-07       Impact factor: 5.113

Review 5.  Closure of patent foramen ovale: technique, pitfalls, complications, and follow up.

Authors:  B Meier
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

Review 6.  [Patent foramen ovale, atrial septum aneurysm, and stroke. An examination of the status of recent evidence].

Authors:  K Kraywinkel; M Jauss; H-C Diener; C Weimar
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

7.  The relationship between migraine and right-to-left shunt in children.

Authors:  Sevcan Sarısoy; Ömer Faruk Aydın; Metin Sungur; Ilkay Koray Bayrak; Servet Aker; Hamit Özyürek; Haydar Ali Taşdemir; Kemal Baysal
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

Review 8.  Role of transcranial Doppler ultrasonography in stroke.

Authors:  Sanjukta Sarkar; Sujoy Ghosh; Sandip Kumar Ghosh; Andrew Collier
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

9.  Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?

Authors:  Alawi A Alsheikh-Ali; David E Thaler; David M Kent
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

Review 10.  Rethinking trial strategies for stroke and patent foramen ovale.

Authors:  David E Thaler; David M Kent
Journal:  Curr Opin Neurol       Date:  2010-02       Impact factor: 5.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.